These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J. Circulation; 1995 Aug 15; 92(4):825-34. PubMed ID: 7641363 [Abstract] [Full Text] [Related]
33. Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man. Flesch G, Müller P, Lloyd P. Eur J Clin Pharmacol; 1997 Aug 15; 52(2):115-20. PubMed ID: 9174680 [Abstract] [Full Text] [Related]
36. Modeling of the pharmacokinetic/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects. Hedaya MA, Helmy SA. Biopharm Drug Dispos; 2015 May 15; 36(4):216-31. PubMed ID: 25545238 [Abstract] [Full Text] [Related]